Menu
Washingtoner
  • Home
  • Financial
  • Home
  • Construction
  • Education
  • Business
  • Technology
  • Marketing
  • Non-profit
Washingtoner

Elixia Announces New Hire Sam Searcy as Chief Commercial Officer
Washingtoner/10209854

Trending...
  • A Statement from the Tacoma City Council Regarding Community Safety Standards and Law Enforcement
  • Yesyal Launches Official Website, Unifying Music, Film, and Apparel Under One Independent Brand
  • Spokane City Council Votes on Department of Justice Grant
Elixia
Sam Searcy joins Elixia, a site management organization, to oversee and increase business growth.

RESEARCH TRIANGLE PARK, N.C. - Washingtoner -- Elixia proudly welcomes Sam Searcy as the company's Chief Commercial Officer. Searcy will oversee activities related to marketing, enhance service offerings, expand Elixia's national site network, maintain client customer service, strategize Elixia's business growth, and increase Elixia's overall market share. Searcy will also manage Elixia's RTP office and the N.C.-based operations team.

"I am thrilled to have the opportunity to work with such a talented team. Elixia is truly implementing a breakthrough approach to clinical trials" Sam Searcy, CCO Searcy joins Elixia as an influential business and community leader with over 10 years of executive leadership roles in small and medium-sized companies in the life science sector. Searcy has a proven track record of building strong, efficient, and productive executive teams, and launching industry-disrupting products and services. Searcy also focuses on community as he serves on a number of corporate and volunteer Boards, including the N.C. Community College System, Appalachian State University Board of Visitors and ICE Global Consulting. He also serves as a Senior Advisor to NeuroVice, a Triangle-based medical device company focused on the medical needs of patients with various seizure disorders.

More on Washingtoner
  • Boston Corporate Coach™ Sets Global Standard for Executive Chauffeur Services Across 680 Cities
  • UK Financial Ltd Announces CoinMarketCap Supply Verification And Market Positioning Review For Regulated Security Tokens SMPRA And SMCAT
  • Sharpe Automotive Redefines Local Car Care with "Transparency-First" Service Model in Santee
  • South Spokane Resident Arrives Home To Find Male Burglarizing Apartment; Resident Assaulted Before Suspect Flees The Area
  • Spokane City Council Votes on Department of Justice Grant

"We are excited to have Sam join the Elixia team. Sam's years of experience in life sciences will help Elixia navigate our current period of rapid growth." Neal Patel, CEO. The addition of Searcy will add value to the Elixia team, accelerate the company's goals, and support Elixia's overall mission.

About Elixia

Elixia is a tech-enabled clinical site organization specializing in Cardiology, Nephrology, Behavioral Health, and Infectious disease trials. Elixia's mission: To provide pharmaceutical companies with a breakthrough approach to clinical trials while empowering physician research, reinventing access to diverse populations, and accelerating the collection of data vital to high-quality clinical research outcomes while comprehensively supporting the drug development process. Elixia maintains corporate headquarters in Palm Beach FL, and the Research Triangle Park.

Contact
Melinda Jackson Public Relations
***@melindajacksonpr.com


Source: Elixia

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • A High-Velocity Growth Story Emerges in Marine and Luxury Markets
  • $26 Billion Global Market by 2035 for Digital Assets Opens Major Potential for Currency Tech Company with ATM Expansion and Deployment Plans Underway
  • Secure AI Acceleration Launches to Make AI Safe to Deploy for Profit
  • Peernovation 365 is Now Available
  • Spokane City Council To Hold Special Legislative Session
  • Snap-a-Box Brings Texas' First Robot-Cooked Chinese Takeout to Katy–Fulshear
  • UK Financial Ltd Makes History as MayaCat (SMCAT) Becomes the World's First Exchange-Traded ERC-3643 Security Token
  • Tacoma: Applicants Sought for the Climate and Sustainability Commission
  • Tacoma: Dr. Martin Luther King, Jr. Celebration Next Week!
  • Narcissist Apocalypse Marks 7 Years as a Leading Narcissistic Abuse Podcast
  • High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
  • CryptaBox Introduces a Hardware Crypto Cold Storage Wallet
  • YWWSDC Launches AI-Native Digital Asset Infrastructure, Merging Technical Innovation with US-Standard Compliance
  • Yesyal Launches Official Website, Unifying Music, Film, and Apparel Under One Independent Brand
  • A Statement from the Tacoma City Council Regarding Community Safety Standards and Law Enforcement
  • High-End Exterior House Painting in Boulder, Colorado
  • Simpson and Reed Co-Founders Shardé Simpson, Esq. and Ciara Reed, Esq. Launch "Hello Wilma,"
  • Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
  • Spokane: City Closures Planned for MLK Jr. Day
  • Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane Police Department and SPD Cadets Engage with the Logan Community to Discuss Crime Prevention in the Neighborhood - 148
  • Spokane: Flags to be Lowered for Trooper Killed in Line of Duty
  • Tacoma: Homicide Investigation – 3500 block of E Grandview Ave
  • City of Tacoma Secures Over $4 Million in Transportation Improvement Board Grants
  • TBM Council Appoints Four Distinguished Leaders to Board of Directors
  • Spokane: City Closures Planned for the Holidays
  • Tacoma: Update in SR-509 Fatal Collision Investigation: Vehicle of Interest Impounded
  • Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Tacoma Police Seeking Vehicle of Interest in Fatal Collision Involving Washington State Patrol Trooper on SR-509

Similar on Washingtoner

  • CCHR White Paper Urges Government Crackdown on Troubled Teen and For-Profit Psychiatric Facilities
  • Automation, innovation in healthcare processes featured at international conference in Atlanta
  • $26 Billion Global Market by 2035 for Digital Assets Opens Major Potential for Currency Tech Company with ATM Expansion and Deployment Plans Underway
  • Secure AI Acceleration Launches to Make AI Safe to Deploy for Profit
  • Peernovation 365 is Now Available
  • Snap-a-Box Brings Texas' First Robot-Cooked Chinese Takeout to Katy–Fulshear
  • UK Financial Ltd Makes History as MayaCat (SMCAT) Becomes the World's First Exchange-Traded ERC-3643 Security Token
  • High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
  • YWWSDC Launches AI-Native Digital Asset Infrastructure, Merging Technical Innovation with US-Standard Compliance
  • Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute